Group 1 - The core point of the article is that U.S. retail sales in August increased by 0.6% month-on-month, surpassing market expectations, indicating strong consumer demand [1] - Year-on-year, retail sales rose by 5%, while the month-on-month growth remained consistent with July's figure of 0.6% [1] - Excluding automotive and parts sales, retail sales increased by 0.7% month-on-month in August [1] Group 2 - Specific categories showed varied performance: automotive and parts sales grew by 0.5%, clothing sales increased by 1%, and online sales rose by 2% [1] - However, furniture and home goods sales experienced a decline of 0.3% month-on-month [1] - Analysts suggest that the growth in retail sales may be influenced by rising prices, as indicated by the Consumer Price Index (CPI) which rose by 2.9% year-on-year and 0.4% month-on-month in August [1]

Core Points - The U.S. President Trump signed an executive order to implement the U.S.-Japan trade agreement, which includes a reduction of tariffs on Japanese cars and parts from 27.5% to 15% [1] - The executive order defines "reciprocal" tariffs and addresses previous disputes regarding cross-border tariffs [1] - Japan has agreed to invest $550 billion in the U.S., with investments to be selected by the U.S. government [2] Group 1 - The executive order officially implements the U.S.-Japan trade agreement [1] - Tariffs on Japanese cars and parts will be reduced to 15%, requiring an administrative process to be completed within seven days of publication in the Federal Register [1] - The order specifies that for Japanese products with existing tariffs below 15%, the total tax rate will be 15%, while products with existing tariffs of at least 15% will have reciprocal tariffs set to zero [1] Group 2 - The measure will apply to Japanese products entering the U.S. market on or after August 7 at 12:01 AM Washington time [1] - The order authorizes the U.S. Secretary of Commerce to modify the reciprocal tariff rates to zero for specific Japanese products, including natural resources and generic drugs [1] - Japan's commitment to invest $550 billion in the U.S. is part of the trade agreement, with the U.S. government having the authority to select the investments [2]